My research sits at the intersection of biomedical and health sciences, the science of science, and complex systems. I use scientometric and data science approaches to examine questions of equity in health research and technological development.

I obtained my PhD in Health Policy and Management from the Universidad Nacional Autónoma de México (UNAM) in 2016, where I was awarded the “Alfonso Caso” Medal for the top graduate of my cohort. I subsequently taught at the UNAM Faculty of Medicine, delivering courses in public health, health information systems, and complex epidemiological systems.

I was awarded a Humboldt Foundation postdoctoral fellowship to conduct research in Berlin, Germany, focusing on the structure, dynamics, and funding of research on CRISPR genome editing technologies. I later held a second postdoctoral position at KU Leuven (Belgium), where I investigated the evolution of health research funding in the European Union and the United States.

I am currently a lecturer at UNAM, where I continue to study the global organization of health research, with a particular focus on the Global South and the implications for science policy and equity.

My work has informed international policy discussions; according to the Overton Database, my research on CRISPR has been cited in policy documents by institutions including the European Parliament, the Food and Agriculture Organization of the United Nations, and the United Nations Conference on Trade and Development.